BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Ulthera CEO - Matthew Likens - to Present at Two Upcoming Healthcare Conferences


11/22/2011 11:30:48 AM

MESA, Ariz., Nov. 22, 2011 /PRNewswire/ -- Matthew Likens, president and CEO of Ulthera, Inc. a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology is scheduled to present at two upcoming healthcare conferences:

-- Tuesday, Nov. 29 at 2:10 p.m. EST

23rd Annual Piper Jaffray Healthcare Conference in New York City, Nov. 29-30, 2011

Location: The New York Palace Hotel, 455 Madison Avenue, New York 10022

-- Tuesday, Dec. 6 at 12:00 p.m. PT

6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference in San Francisco, Dec. 6, 2011

Location: St. Regis, 125 3rd Street, San Francisco 94103

Likens will present an overview of the company as well as its accomplishments to date and prospects for the future.

(Logo: http://photos.prnewswire.com/prnh/20111122/NY10856LOGO )

About Ulthera
Ulthera®, Inc. is a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy® the procedure enabled by the System is a non-invasive face and neck treatment to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ulthera.com.

SOURCE Ulthera, Inc.


Read at BioSpace.com


Ulthera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->